Home › Cardiotoxicity › New York
Cardiotoxicity clinical trials in New York
4 studies for Cardiotoxicity are looking for participants at sites in New York.
Cities in New York
Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients
- Memorial Sloan-Kettering Cancer Center, New York
RecruitingObservational study
Ages 18 and older · Women · Updated Jun 3, 2026 · NCT02772367AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
- Mount Sinai Hospital, New York
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jun 1, 2026 · NCT06699056A Study of Blood Pressure Control During Cancer Treatment
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- and 1 more
RecruitingPhase 2
Ages 18 and older · Women · Updated May 14, 2026 · NCT06023576S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- Nyack Hospital, Nyack
- Dickstein Cancer Treatment Center, White Plains
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 8, 2025 · NCT03418961From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.